Scaffold treatment was an independent predictor of efficacy (odds ratio, 0.27; P =0.0003) and showed a trend toward reduced risk of clinically driven target lesion revascularization, though this did not reach statistical significance.
← all excerpts
Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial.
1
—
—